Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MTFB

MOTIF BIO PLC/S (MTFB) Stock Price, News & Analysis

MOTIF BIO PLC/S logo

About MOTIF BIO PLC/S Stock (NASDAQ:MTFB)

Advanced Chart

Key Stats

Today's Range
$0.10
$0.12
50-Day Range
$0.10
$0.11
52-Week Range
$0.08
$11.50
Volume
867,698 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.

Receive MTFB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MOTIF BIO PLC/S and its competitors with MarketBeat's FREE daily newsletter.

MTFB Stock News Headlines

Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…
DAVA - Endava plc
See More Headlines

MTFB Stock Analysis - Frequently Asked Questions

MOTIF BIO PLC/S (MTFB) raised $17 million in an initial public offering (IPO) on Friday, November 18th 2016. The company issued 2,400,000 shares at $6.98 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that MOTIF BIO PLC/S investors own include Sorrento Therapeutics (SRNE), Allergan (AGN), Ampliphi Biosciences (APHB), Neurocrine Biosciences (NBIX), Bristol-Myers Squibb (BMY), Canopy Growth (CGC) and Forward Pharma A/S (FWP).

Company Calendar

Today
5/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MTFB
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:MTFB) was last updated on 5/9/2025 by MarketBeat.com Staff
From Our Partners